GlobeNewswire Inc.··NaArcutis Reports Strong 2025 Revenue Growth, Raises 2026 Outlook
Arcutis reported 2025 revenue of $372.1M (123% growth) and raised 2026 guidance to $480-495M, driven by strong ZORYVE adoption and positive clinical data.
ARQTQ4 2025 earningsFDA approval